• Tel: 858.663.9055
  • SeparatorEmail: info@nsjbio.com
  • Tel: 858.663.9055
  • Email: info@nsjbio.com
Home >> Antibodies >> HLA-DQ Antibody SPV-L3 / MHC Class II Antibody

HLA-DQ Antibody SPV-L3 / MHC Class II Antibody [clone SPV-L3] (V2581)

  Catalog No Formulation Size Price (USD)  
Image V2581-100UG 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide 100 ug 559
Image
V2581-20UG 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide 20 ug 259
Image
V2581SAF-100UG 1 mg/ml in 1X PBS; BSA free, sodium azide free 100 ug 559
Bulk quote request
HLA-DQ Antibody SPV-L3 in Human Raji B Lymphoma Cells FACS. Flow cytometry testing of human Raji B lymphoma cells with HLA-DQ Antibody SPV-L3 / MHC Class II Antibody. The antibody-stained population (blue) shows a clear fluorescence shift relative to the isotype control (red), demonstrating detection of cell-surface HLA-DQ.
Purified HLA-DQ Antibody SPV-L3 SDS-PAGE. Electrophoretic analysis of purified, BSA-free HLA-DQ Antibody SPV-L3 / MHC Class II Antibody under non-reducing (NR) and reducing (R) conditions using a 2 ug antibody load. The non-reduced antibody migrates predominantly near ~150 kDa, while reduction produces immunoglobulin heavy and light chain components near ~50 kDa and ~25 kDa, respectively, supporting the integrity and purity of the antibody preparation.
Availability 1-3 business days
Species Reactivity Human
Format Purified
Host Mouse
Clonality Monoclonal (mouse origin)
Isotype Mouse IgG2a, kappa
Clone Name SPV-L3
Purity Protein G affinity chromatography
UniProt P01908 , P01909 , P01920
Localization Cell surface
Applications Flow Cytometry : 1-2ug/million cells
Immunofluorescence : 1-2ug/ml
Limitations This HLA-DQ Antibody SPV-L3 / MHC Class II Antibody is available for research use only.
Review this product on BioCompare and get a $20 Amazon gift card

Related Products

Description

HLA-DQ Antibody SPV-L3 / MHC Class II Antibody recognizes human HLA-DQ, a classical major histocompatibility complex (MHC) class II molecule that functions in antigen presentation to CD4-positive T lymphocytes. HLA-DQ contributes to adaptive immune recognition by displaying processed antigenic peptides at the cell surface, where peptide-MHC complexes can be surveyed by T cell receptors. Recognition of an appropriate complex promotes helper T cell activation and contributes to the coordination of cellular and humoral immune responses.

HLA-DQ is a heterodimer composed of an alpha chain encoded principally by HLA-DQA1 and a beta chain encoded by HLA-DQB1. Both chains contribute to formation of the extracellular peptide-binding groove. Extensive polymorphism within HLA-DQ influences the repertoire of peptides that can be presented and contributes to differences in immune recognition among individuals. Particular HLA-DQ alleles and haplotypes have been associated with susceptibility or resistance to multiple immune-mediated diseases, making HLA-DQ an important focus in immunogenetics and autoimmune disease research.

HLA-DQ is expressed predominantly by professional antigen-presenting cells, including B lymphocytes, dendritic cells and macrophages. Expression can also be induced or enhanced in additional cell types in response to inflammatory signaling. Antigens internalized by antigen-presenting cells are processed primarily within endosomal compartments, where resulting peptides can be loaded onto MHC class II molecules before peptide-HLA complexes are transported to the plasma membrane for CD4 T cell recognition.

HLA-DQ Antibody reagents are useful for investigating MHC class II expression, antigen-presenting cell populations and HLA-DQ-dependent immune recognition. HLA-DQ biology is particularly relevant to studies of autoimmunity, infectious disease, transplantation, inflammation and adaptive immune regulation. Antibodies directed against HLA-DQ also complement reagents targeting HLA-DP and HLA-DR, allowing researchers to distinguish individual components of the classical MHC class II system from broader pan-HLA class II expression.

Clone SPV-L3 is an established mouse monoclonal antibody directed against human HLA-DQ and has been extensively used in published research. NSJ Bioreagents provides this HLA-DQ Antibody for studies of MHC class II biology, antigen presentation and immune-cell recognition. An MHC Class II Antibody targeting HLA-DQ can support investigation of HLA-DQ-positive cell populations and mechanisms connecting peptide presentation with CD4 T cell-mediated immunity.

Explore our Immunology Antibodies page for additional reagents targeting MHC molecules, antigen presentation and adaptive immune responses.

Application Notes

Optimal dilution of the HLA-DQ Antibody SPV-L3 / MHC Class II Antibody should be determined by the researcher.

Immunogen

The T4-positive CTL clone HG-38 was used as the immunogen for the HLA-DQ Antibody SPV-L3.

Storage

Store the HLA-DQ Antibody SPV-L3 at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Alternate Names

HLA-DQ antibody, MHC Class II antibody, HLA Class II DQ antibody, HLA-DQ MHC II antibody, SPV-L3 antibody

Cross
Bulk Quote Request Form
Name*:
Organization*:
Email*:
Phone Number*:
Catalog No.*:
Comments and Specifics(amount, formulation, etc.)*:
Validation code: Captchapackage Image


Can't read the image? click here to refresh.
    *required field

Your bulk quote request has been submitted successfully!

Please contact us if you have any questions.